Breast Cancer 1000 Project 2016-2017: Discovering genes that collaborate with mutant TP53 to drive breast cancer aggressiveness (ASUF 30007274)

Medicine & Life Sciences

1. Epitopes 100%
2. Breast Neoplasms 89%
3. Triple Negative Breast Neoplasms 70%
4. HLA-A Antigens 64%
5. Genes 56%
6. Mutation 42%
7. Cancer Vaccines 42%
8. T-Lymphocyte Epitopes 42%
9. Peptides 40%
10. Immunity 38%
11. Neoplasm Antigens 31%
12. HLA-B Antigens 22%
13. T-Lymphocytes 21%
14. Antigens 18%
15. Vaccines 17%
16. Computational Biology 16%
17. Enzyme-Linked Immunospot Assay 15%
18. Immunotherapy 15%
19. Comparative Genomic Hybridization 13%
20. Neoplasms 13%
21. Alleles 12%
22. Interferons 10%
23. In Vitro Techniques 10%
24. HLA-B57 antigen 10%
25. Theoretical Models 9%
26. Chromosomes 9%
27. Tissue Donors 9%
28. T-Cell Antigen Receptor Specificity 8%
29. Combined Vaccines 7%
30. Immunologic Monitoring 7%
31. Null Lymphocytes 7%
32. Exome 6%
33. Cell Line 6%
34. Hydrophobic and Hydrophilic Interactions 6%
35. Antigen Presentation 6%
36. HLA-DR Antigens 6%
37. Preliminary Data 6%
38. Residual Neoplasm 6%
39. Proteome 6%
40. HLA Antigens 5%
41. Genomics 5%
42. Cellular Immunity 5%
43. Proteomics 5%
44. Mass Spectrometry 5%
45. Ovary 5%